DEVELOP SAFE AND POTENT DRUGS THAT CAN TURN THE TUMOR IMMUNE MICROENVIRONMENT FROM SUPPRESSIVE TO PERMISSIVE, THEREBY HELPING THE IMMUNE SYSTEM TO RECOGNIZE AND KILL GLIOBLASTOMA.

PIs: Jian Hu, Ph.D.
Associate Professor, Department of Cancer Biology, Division of Basic Science Research
University of Texas MD Anderson Cancer Center

PIs: Dr. Yiwen Chen, Ph.D.
Assistant Professor, Department of Bioinformatics and Computational Biology
University of Texas MD Anderson Cancer Center

Close Menu